CSL - Equity Capital And Reserves

Stock Price
138.16
Daily Change
3.54 2.63%
Monthly
-6.26%
Yearly
-45.61%
Q1 Forecast
138.07

CSL reported $18.66B in Equity Capital and Reserves for its fiscal semester ending in December of 2025.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 22.81M 5.29M Jun/2023
Arca Biopharma USD 469M 17.79M Dec/2025
aTyr Pharma USD -24.12M 104.35M Dec/2025
Bio Path USD -8M 846K Sep/2025
Brainstorm Cell Therapeutics USD -7.69M 1.64M Sep/2025
Cara Therapeutics USD 32.93M 41M Jun/2025
CSL USD 18.66B 2.75B Dec/2025
Curis USD -13.99M 7.38M Jun/2025
Esperion Therapeutics USD -301.96M 149.4M Dec/2025
Immunic USD 10.5M 23.41M Sep/2025
Infinity Pharmaceuticals USD -37.41M 9.08M Jun/2023
Minerva Neurosciences USD -140.75M 106.17M Dec/2025
Sangamo BioSciences USD 19.6M 14.7M Jun/2025
TherapeuticsMD USD 27.67M 990K Jun/2024